Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer.

PURPOSE To clarify the risk of developing second primary cancers (SPCs) after radiotherapy (RT) versus prostatectomy for localized prostate cancer (PCa) in the modern era. METHODS The RT cohort consisted of 2120 patients matched on a 1:1 basis with surgical patients according to age and follow-up time. RT techniques consisted of conventional or two-dimensional RT (2DRT, 36%), three-dimensional conformal RT and/or intensity modulated RT (3DCRT/IMRT, 29%), brachytherapy (BT, 16%), and a combination of 2DRT and BT (BT boost, 19%). RESULTS The overall SPC risk was not significantly different between the matched-pair (HR 1.14, 95% CI 0.94-1.39), but the risk became significant >5years or >10years after RT (HR 1.86, 95% CI 1.36-2.55; HR 4.94, 95% CI 2.18-11.2, respectively). The most significant sites of increased risk were bladder, lymphoproliferative, and sarcoma. Of the different RT techniques, only 2DRT was associated with a significantly higher risk (HR 1.76, 95% CI 1.32-2.35), but not BT boost (HR 0.83, 95% CI 0.50-1.38), 3DCRT/IMRT (HR 0.81, 95% CI 0.55-1.21), or BT (HR 0.53, 95% CI 0.28-1.01). CONCLUSIONS Radiation-related SPC risk varies depending on the RT technique and may be reduced by using BT, BT boost, or 3DCRT/IMRT.

[1]  F. Langmark,et al.  Relationship of leukemia risk to radiation dose following cancer of the uterine corpus. , 1994, Journal of the National Cancer Institute.

[2]  F. Vicini,et al.  Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control. , 1996, International journal of radiation oncology, biology, physics.

[3]  Umberto Capitanio,et al.  The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. , 2010, International journal of radiation oncology, biology, physics.

[4]  C R Blackwell,et al.  Fetal dose from radiotherapy with photon beams: report of AAPM Radiation Therapy Committee Task Group No. 36. , 1995, Medical physics.

[5]  G. Gustafson,et al.  Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  M Hagan,et al.  A comparison of HDR brachytherapy and IMRT techniques for dose escalation in prostate cancer: a radiobiological modeling study. , 2009, Medical physics.

[7]  J. Ruben,et al.  The effect of intensity-modulated radiotherapy on radiation-induced second malignancies. , 2008, International journal of radiation oncology, biology, physics.

[8]  M. Soloway,et al.  Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. , 2008, The Journal of urology.

[9]  G. Nicholas,et al.  Prostatic irradiation is not associated with any measurable increase in the risk of subsequent rectal cancer. , 2006, International journal of radiation oncology, biology, physics.

[10]  P. Scalliet,et al.  A Dosimetric Selectivity Intercomparison of HDR Brachytherapy, IMRT and Helical Tomotherapy in Prostate Cancer Radiotherapy , 2009, Strahlentherapie und Onkologie.

[11]  Luca Cozzi,et al.  A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  P. Levendag,et al.  Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study. , 1999, International journal of radiation oncology, biology, physics.

[13]  James A Purdy,et al.  DOSE TO NORMAL TISSUES OUTSIDE THE RADIATION THERAPY PATIENT’S TREATED VOLUME: A REVIEW OF DIFFERENT RADIATION THERAPY TECHNIQUES , 2008, Health physics.

[14]  H. Dohy,et al.  Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. , 1994, Radiation research.

[15]  M. Soloway,et al.  Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk? , 2007, European urology.

[16]  E Bezak,et al.  Risk of second primary cancer following prostate cancer radiotherapy: DVH analysis using the competitive risk model , 2009, Physics in medicine and biology.

[17]  D. Theodorescu,et al.  Cancer incidence after localized therapy for prostate cancer , 2006, Cancer.

[18]  L. Potters,et al.  Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. , 2002, International journal of radiation oncology, biology, physics.

[19]  W. Dörr,et al.  Second Primary Tumors after Radiotherapy for Malignancies Treatment-Related Parameters , 2002, Strahlentherapie und Onkologie.

[20]  E. Bergstralh,et al.  Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. , 2005, The Journal of urology.

[21]  A. Neugut,et al.  Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma , 1997, Cancer.

[22]  Tom Pickles,et al.  The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  J. Blasko,et al.  Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. , 2006, International journal of radiation oncology, biology, physics.

[24]  D. Preston,et al.  Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. , 1994, Radiation research.

[25]  E. Hall,et al.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT. , 2003, International journal of radiation oncology, biology, physics.

[26]  J Wong,et al.  Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer. , 2001, International journal of radiation oncology, biology, physics.

[27]  G E Hanks,et al.  Is there an increased risk of second primaries following prostate irradiation? , 1998, International journal of radiation oncology, biology, physics.

[28]  D. Brenner,et al.  Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery , 2000, Cancer.

[29]  G. Gustafson,et al.  High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. , 2004, The Journal of urology.

[30]  Joel E Tepper,et al.  Increased risk of rectal cancer after prostate radiation: a population-based study. , 2005, Gastroenterology.